Skip to content

Pillar

Stress

What stress does in autoimmune disease, why the claim that it sets off flares is far thinner than you're told, and what treating it does and doesn't fix.

Free download

The First Changes to Make.

The same handout I hand my own patients: the specific food and daily-exposure changes worth making first, no guesswork required.

No spam · Unsubscribe any time
Quick answerPeople with a stress disorder go on to get more autoimmune disease, at a hazard ratio of 1.36, even against their own brothers and sisters. Once you already have the disease, rising stress predicts worse scores over the following year. Trials of stress reduction lift mood reliably and leave the inflammation alone.
The claim that stress sets off flares is the most overstated thing written here, and it's worth pulling apart from the claims that hold. One review of stress in rheumatoid arthritis found 16 studies using 13 different questionnaires between them, which is why no pooled figure exists. No trial has defined a flare properly and then tested stress ahead of it as the trigger. Three things are well supported: stress disorders come before autoimmune disease, distress predicts worse outcomes, and treating distress helps how people feel without lowering inflammation.

What the research found.

  • A Swedish record study followed 106,464 people diagnosed with a stress disorder, 1,064,640 matched people, and 126,652 of their own brothers and sisters. Autoimmune disease came in at 9.1 per 1,000 person-years in the stress group, against 6.0 in the matched group and 6.5 in the siblings, at a hazard ratio of 1.36. The sibling comparison is what gives that its weight, because brothers and sisters share an upbringing and much of their genetics. Post-traumatic stress disorder came in higher still, at 1.46 for any autoimmune disease and 2.29 for having three or more.

    Song and colleagues, JAMA, 2018

  • Mindfulness in rheumatoid arthritis gave a DAS28-CRP effect, a change on the combined disease-activity score that uses CRP as its blood marker, of minus 0.44, and a pain effect of minus 0.58, across five trials and 399 people. Neither of those counted as real. Mood improved in all four trials that measured it, which is the pattern across this whole literature.

    DiRenzo and colleagues, Current Rheumatology Reports, 2018

  • One trial tested talking therapy for long-term stress in lupus, over ten weekly sessions with fifteen months of follow-up. Low mood, worry, daily stress, and quality of life all improved. The authors report no real change in any immune measure they took, and they took several of them.

    Navarrete-Navarrete and colleagues, Psychotherapy and Psychosomatics, 2010

  • One review of stress in rheumatoid arthritis screened 11,115 records and kept just 16 studies. Those 16 used 13 different questionnaires between them. So no pooled figure was possible at all, which is a finding about the state of the field rather than about stress.

    De Cock and colleagues, Seminars in Arthritis and Rheumatism, 2022

  • Some lupus patients in a three-year study had their felt stress rise by half a standard deviation or more, and their scores followed. Doctor-rated disease activity came in at 3.7, against 2.5 in the people holding stable or improving. Self-rated activity was 12.2 against 8.2, and pain and fatigue ran in that direction too.

    Patterson and colleagues, Arthritis Care and Research, 2023

  • A separate study followed 666,269 Iraq and Afghanistan veterans. Post-traumatic stress disorder came out at a relative risk of 2.00 against veterans with no mental health diagnosis, and 1.51 against veterans with other mental health diagnoses. That second figure is the useful one, because it points at something specific to post-traumatic stress and not to mental illness in general.

    O'Donovan and colleagues, Biological Psychiatry, 2015

  • A 24-year group of 54,763 women found trauma linked to new lupus at a hazard ratio of 2.83, and probable post-traumatic stress disorder at 2.94, from 1.19 to 7.26. Only 73 women in the whole group developed lupus, so the direction is clear and the size isn't. A range that wide is a reason to hold the figure loosely.

    Roberts and colleagues, Arthritis and Rheumatology, 2017

  • One review pooled 27 studies covering 8,728 cases. Hard childhood experiences were associated with adult autoimmune disease at a standardized mean difference of 0.30. Then the authors tested for publication bias and found it, at an Egger z of 2.17 and a P value of 0.003, and filling in 14 missing studies dropped the pooled figure to 0.11, from 0.02 to 0.20. The smaller number is the one to remember.

    Jesuthasan and colleagues, Brain, Behavior, and Immunity, 2025

What the strongest evidence shows

The strongest study here is a Swedish record comparison, and what makes it strong is that it set people with a stress disorder against their own brothers and sisters. Siblings share an upbringing and much of their genetics, so a difference between them is a good deal harder to explain away. Post-traumatic stress disorder shows a bigger effect than other stress disorders, in that study and in a large veteran study built differently. Trauma has been linked to new lupus as well, in a group followed for more than two decades, and the numbers with their ranges are in the list above.

Childhood adversity, and what publication bias does to it

Hard childhood experiences have been linked to adult autoimmune disease across dozens of studies, and the headline figure from the largest review is the one everybody quotes. That review tested whether the published studies lean one way, found that they do, and corrected for it. Correcting shrank a moderate link to a very small one, and the corrected figure is the honest one. The study designs point that way too, because asking people to recall their childhood after they're already ill gives a bigger answer than watching them from the start.

The flare claim

This is where writing on stress goes furthest past its evidence, and the absence underneath it is worth saying plainly. One review screened 11,115 records and kept 16 studies, and those 16 used 13 different questionnaires between them, so nothing could be pooled at all. No trial has defined a flare by proper criteria and then tested stress ahead of it as the trigger. That's a flat absence and not a mixed result, and the claim gets repeated with confidence anyway.

What treating it achieves, and which direction it runs

The trials agree with each other, and what they agree on isn't what most people expect. Mood improves reliably and the immune numbers don't follow it. Mindfulness in rheumatoid arthritis moved neither disease activity nor pain by enough to count, and a lupus trial of talking therapy improved low mood, worry, and quality of life while reporting no real change in any immune measure.

Most of this evidence can't tell stress causing disease trouble apart from disease causing stress, and in axial spondyloarthritis disease activity predicted low mood at a correlation of 0.607 and a regression coefficient of 0.711. So getting your disease well controlled is one of the more reliable stress treatments you have. You also shouldn't be told your disease would be quieter if you managed your stress better, since the trials built to show that didn't show it.

What to do this week.

1

Treat the disease, and you treat the stress

Getting your disease well controlled is one of the more reliable stress treatments available to you. It rarely gets framed that way, and the evidence behind it is better than the evidence behind most of what does.

2

Ask what talking therapy is available

Talking therapy and mindfulness both have good evidence for low mood, worry, distress, and pain getting in the way. Ask your team what you can get, because the online versions did as well as the in-person ones.

3

Skip the cortisol panel

Saliva cortisol panels sold direct to you have no proven use in these diseases, and there's no target value to aim at. If somebody hands you a result with a treatment plan attached, the evidence under that plan doesn't exist.

4

Don't accept the flare story

If you're told a stressful week brought your flare on, ask which study showed that. The study that would show it has never been run, and you shouldn't be handed the blame for your own disease.

Common misconceptions.

Myth. Meditation doesn't work for me.

Reality. Meditation is one tool of many. Breathwork, cold exposure, HRV biofeedback, yoga, and structured movement all train the same vagal tone. If appearing in silence doesn't work for you, that doesn't mean nothing will.

In plain words. Meditation is one tool, not the only one. Breathing, cold, yoga, and movement all train your nervous system to settle. If sitting still isn't for you, try another door.

Myth. I just need to manage my stress better.

Reality. Some stressors can't be reduced. The work is building central pain pathways capacity to recover from stress quickly, not eliminating stress. Recovery is the trainable variable, not exposure.

In plain words. You can't delete stress from your life. What you can train is how fast you bounce back. It's like fitness. You don't avoid the hill, you get better at climbing it.

Questions patients ask.

Does stress cause autoimmune disease?

The best evidence says it raises the risk without proving cause. A Swedish record study covered 106,464 people with a stress disorder, and autoimmune disease came in at a hazard ratio of 1.36, holding up even against their own brothers and sisters. For post-traumatic stress disorder the figures were higher still. That's a careful measurement of a real link, and watching people can never prove cause on its own.

Does stress trigger flares?

This is the claim to watch. One review of stress in rheumatoid arthritis kept 16 studies using 13 different questionnaires, so nothing could be pooled, and no trial has defined a flare properly and then tested stress ahead of it as the trigger. Rising stress does predict worse disease scores in lupus, which is related to that claim without being it.

Will managing my stress lower my inflammation?

Probably not in any way anybody could measure. Mindfulness in rheumatoid arthritis gave a DAS28-CRP effect, a change on the combined disease-activity score that uses CRP as its blood marker, of minus 0.44 and a pain effect of minus 0.58, and neither counted as real. A lupus trial of talking therapy improved low mood, worry, and quality of life, and reported no real change in disease scores, antibodies, or complement. Mood improves reliably, and the immune numbers don't follow it.

So is stress management worth doing?

Yes, for what it does rather than for what it's sold as. Low mood, worry, distress, and pain getting in the way all improve in these trials, and living with a long-term disease is hard enough that those count on their own. Online mindfulness and online talking therapy did equally well against a waiting list in 269 rheumatoid arthritis patients.

What does cortisol have to do with it?

Less than you'll be told, and not in the direction you'd expect. The only cortisol study here is small, with 24 people who had active rheumatoid arthritis, and higher daily cortisol predicted reaching remission rather than worse disease. There's no tested cortisol measure here, no target value, and nothing to act on. Cortisol panels sold direct to you have no proven use in these diseases.

Is my disease causing the stress, or the other way round?

Both, as far as anybody can tell. In axial spondyloarthritis, disease activity tracked low mood at 0.607, so active disease clearly causes distress by itself. The record study and the veteran study measured stress before any autoimmune disease existed at all, which means it runs the other way too. So getting your disease under control is one of the more reliable stress treatments you have.

References.

  1. Song H; Fang F; Tomasson G et al. Association of Stress-Related Disorders With Subsequent Autoimmune Disease. JAMA. 2018;319:2388. 10.1001/jama.2018.7028Population- and sibling-matched retrospective cohort study
  2. O’Donovan A; Cohen B; Seal K et al. Elevated Risk for Autoimmune Disorders in Iraq and Afghanistan Veterans with Posttraumatic Stress Disorder. Biological Psychiatry. 2015;77:365-374. 10.1016/j.biopsych.2014.06.015Retrospective cohort study of 666
  3. Roberts A; Malspeis S; Kubzansky L et al. Association of Trauma and Posttraumatic Stress Disorder With Incident Systemic Lupus Erythematosus in a Longitudinal Cohort of Women. Arthritis & Rheumatology. 2017;69:2162-2169. 10.1002/art.40222Longitudinal cohort study
  4. Dube S; Fairweather D; Pearson W et al. Cumulative Childhood Stress and Autoimmune Diseases in Adults. Psychosomatic Medicine. 2009;71:243-250. 10.1097/PSY.0b013e3181907888Retrospective cohort with prospective follow-up through 2005
  5. Jesuthasan J; Watson C; Hafeez D et al. Childhood adversity as a risk factor for autoimmune disease: A systematic review and meta-analysis with implications for psychiatry. Brain, Behavior, and Immunity. 2025;128:643-653. 10.1016/j.bbi.2025.04.036Systematic review and meta-analysis of observational studies
  6. De Cock D; Doumen M; Vervloesem C et al. Psychological stress in rheumatoid arthritis: a systematic scoping review. Seminars in Arthritis and Rheumatism. 2022;55:152014. 10.1016/j.semarthrit.2022.152014Systematic scoping review of psychological stress in rheumatoid arthritis
  7. Patterson S; Trupin L; Hartogensis W et al. Perceived Stress and Prediction of Worse Disease Activity and Symptoms in a Multiracial, Multiethnic Systemic Lupus Erythematosus Cohort. Arthritis Care & Research. 2023;75:1681-1689. 10.1002/acr.25076Prospective longitudinal observational cohort
  8. Sweeney M; Adas M; Cope A et al. Longitudinal effects of affective distress on disease outcomes in rheumatoid arthritis: a meta-analysis and systematic review. Rheumatology International. 2024;44:1421-1433. 10.1007/s00296-024-05574-9Systematic review and meta-analysis of longitudinal observational studies
  9. DiRenzo D; Crespo-Bosque M; Gould N et al. Systematic Review and Meta-analysis: Mindfulness-Based Interventions for Rheumatoid Arthritis. Current Rheumatology Reports. 2018;20. 10.1007/s11926-018-0787-4Systematic review and meta-analysis of mindfulness-based interventions in rheumatoid arthritis
  10. Navarrete-Navarrete N; Peralta-Ramírez M; Sabio-Sánchez J et al. Efficacy of Cognitive Behavioural Therapy for the Treatment of Chronic Stress in Patients with Lupus Erythematosus: A Randomized Controlled Trial. Psychotherapy and Psychosomatics. 2010;79:107-115. 10.1159/000276370Randomised controlled trial
  11. Zautra A; Davis M; Reich J et al. Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression.. Journal of Consulting and Clinical Psychology. 2008;76:408-421. 10.1037/0022-006X.76.3.408Randomised controlled trial
  12. Pradhan E; Baumgarten M; Langenberg P et al. Effect of Mindfulness‐Based stress reduction in rheumatoid arthritis patients. Arthritis Care & Research. 2007;57:1134-1142. 10.1002/art.23010Randomised controlled trial
  13. Sharpe L; Bisby M; Menzies R et al. A Tale of Two Treatments: A Randomised Controlled Trial of Mindfulness or Cognitive Behaviour Therapy Delivered Online for People with Rheumatoid Arthritis. Psychotherapy and Psychosomatics. 2025:1-12. 10.1159/000542489Randomised controlled trial
  14. Filippa M; Yavropoulou M; Vlachogiannis N et al. Individual Cortisol Production in Active Rheumatoid Arthritis Associates with Treatment Responses: A Pilot, Two-Year Study. Mediterranean Journal of Rheumatology. 2025;36:193. 10.31138/mjr.131224.ipcProspective pilot observational study
  15. Schiestl L; Wendt E; Proft F et al. Interrelations of disease activity, health-related quality of life, and mental health in axial spondyloarthritis: the Rheuma-VOR cohort. Frontiers in Medicine. 2026;13. 10.3389/fmed.2026.1823684Longitudinal prospective observational cohort

This page gathers the published research on this subject into one place. The studies behind it were published between 1989 and 2026, and every figure links to the paper it came from. Those studies were peer reviewed. This summary of them was not. Dr. Sarah Luebker is reviewing these pages one at a time and has not reached this one yet, so it carries no medical review date and nothing here is her opinion or her advice to you. Each page gets updated as she reaches it. It is here in the meantime because the science is worth having in one organized place that is easy to find and easy to read. Talk to your own clinician before acting on any of it.